The laws governing the two sectors take different approaches in several areas, such as the size of personal crops and the number of licenses that must be granted to merchants for the cultivation, distribution, and processing of the plant.
For the first time in the legislative history of Spain, it is considered a serious offense to have marijuana plants visible from the street even if they are for self-consumption– that is not fined if it is not done in public –
On the other hand, the deputy of Ciudadanos Noemi de la Calle has announced that her group shares the content of the law, but has indicated that some aspects can generate “frustrations”
The Medical Cannabis Research Act of 2018 are being backed by 24 federal lawmakers, which include Matt Gaetz and House Judiciary Chairman Bob Goodlatte. This will help facilitate the approved federal clinics which involves cannabis.
It will also help end the existing monopoly at the University of Mississippi on the cannabis’ growth. As you all know, the growth is for medical purposes, which requires licensing of added manufacturers.
In Paul Armentano’s article, he talks about the production monopoly in marijuana:
Currently, the US National Institute on Drug Abuse designates the University of Mississippi to be the sole provider of marijuana for FDA-approved research. However, many of those familiar with their product have criticized its quality, opining that it possesses subpar potency, is often poorly manicured, and that it does not accurately reflect the wide variety of cannabis products and strains available to consumers. Continue reading full post here…
Will the monopoly of Marijuana be stopped? That is what we need to find out in the next future.
With cannabis becoming legal in Paris, the number of sellers are also increasing. In fact, there are two coffee shops who are selling legal cannabis. This may be the reason for the long lines that are seen by many outside the coffee shop since everyone is eager to purchase cannabis now.
Some are lining up because they are curious about the medicinal purposes of the cannabis being sold today. There are also some who are curious if the cannabis that these coffee shops have can indeed make them stoned, since the ones being sold have higher contents of CBD.
In this article by David Chazan, he talks about this long lines at these coffee shops where people are eager to get their hands on these legal cannabis:
The shops opened last week following a softening of restrictions to allow the sale of cannabis containing less than 0.2 per cent of THC (tetrahydrocannabinol), the main psychoactive ingredient.
The shops’ owners insist that their hemp products will not induce the ‘high’ craved by drug users and are purely for those who like the taste and aroma. Although the cannabis has very little THC, it does contain a relaxant.
Joaquim Lousquy, 29, the owner of ‘Cofyshop’ in the hip 11th arrondissement, said: “There’s no psychotropic effect. It isn’t a medicine or a relaxant. I wouldn’t advise anyone to smoke cannabis. We sell it like any other item, just like a furniture shop sells tables or chairs.” Continue reading here..
With the new legislation by two dozen different federal lawmakers, and as well as Matt Gaetz and House Judiciary Chairman Bob Goodlatte, they have finally passed The Medical Cannabis Research Act of 2018. This law will assist in facilitating any clinical trials that are approved. These clinical trials will of course involved cannabis. With this law, there is no need for a manufacturer to secure a license. This also means that manufacturers can easily conduct clinical trials, not only for their benefits, but as well as for the public.
Another good thing about this law is that University of Mississippi, which is the sole marijuana provider, will have competitors. Especially that there are people who are complaining about the quality of their marijuana. To give you a clearer view, this article by Pail Armentano will tell you more about it:
Currently, the US National Institute on Drug Abuse designates the University of Mississippi to be the sole provider of marijuana for FDA-approved research. However, many of those familiar with their product have criticized its quality, opining that it possesses subpar potency, is often poorly manicured, and that it does not accurately reflect the wide variety of cannabis products and strains available to consumers.
Previous efforts to break this monopoly have so far been unsuccessful. In 2007, DEA Administrative Law Judge Mary Ellen Bittner determined that expanding the pool of federally licensed providers would be “in the public interest.” The agency ultimately rejected her decision. More recently, in 2016, the DEA changed its position and amended regulations in a manner to permit additional applicants to apply to federal licensure to grow marijuana. However, the Justice Department and the US Attorney General have thus far failed to take action on any pending applications. Continue reading here..
Hopefully, this will be a start of the wide medical marijuana use all over the world.